Literature DB >> 16186524

Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease.

R Kern1, W Steinke, M Daffertshofer, R Prager, M Hennerici.   

Abstract

BACKGROUND: Although the natural history of extracranial carotid artery disease has been investigated systematically, limited data are available on the course of middle cerebral artery (MCA) disease.
METHODS: The authors observed 102 consecutive patients (67 men, 35 women; mean age 61.9 years) with significant MCA stenosis or occlusion as demonstrated by transcranial Doppler and transcranial color-coded duplex ultrasonography. Forty-six patients entered the study after TIA (n = 17) or stroke (n = 29); 56 patients were asymptomatic. Neurologic and ultrasound investigations were performed at regular intervals with a mean follow-up of 31 (range 6 to 117) months. Patients were continuously treated with either platelet inhibitors (n = 75) or anticoagulation (n = 27).
RESULTS: Nineteen cerebral ischemic events (11 strokes, 8 TIAs) occurred during follow-up, resulting in an overall annual rate of 7.3%. Thirteen events (8 strokes, 5 TIAs) were attributable to the vascular territory ipsilateral to MCA disease. Patients with symptomatic MCA disease at study entry had an overall stroke risk of 12.5% per year (ipsilateral: 9.1%), whereas the annual incidence in primarily asymptomatic MCA disease was only 2.8% (ipsilateral: 1.4%; p < 0.01). Symptomatic MCA disease was an independent predictor for overall (hazard ratio [HR] 7.91, 95% CI 2.03 to 30.79; p < 0.01) and ipsilateral (HR 9.66, 95% CI 1.5 to 62.25; p = 0.02) cerebrovascular events.
CONCLUSIONS: Compared with asymptomatic middle cerebral artery disease, there was a high and continuous recurrence rate of ischemic events in symptomatic patients, which was even higher than in patients with symptomatic extracranial carotid artery disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186524     DOI: 10.1212/01.wnl.0000175983.76110.59

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  53 in total

Review 1.  [Endovascular treatment for intracranial stenoses. A common statement by neurologists and neuroradiologists].

Authors:  J Berkefeld; G F Hamann; R du Mesnil; W Kurre; H Steinmetz; F E Zanella; M Sitzer
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

2.  Prevalence and prognosis of coexistent asymptomatic intracranial stenosis.

Authors:  Fadi Nahab; George Cotsonis; Michael Lynn; Edward Feldmann; Seemant Chaturvedi; J Claude Hemphill; Richard Zweifler; Karen Johnston; David Bonovich; Scott Kasner; Marc Chimowitz
Journal:  Stroke       Date:  2008-01-31       Impact factor: 7.914

3.  Non-moyamoya vessel network formation along steno-occlusive middle cerebral artery.

Authors:  Yu-Yuan Xu; Ming-Li Li; Shan Gao; Bo Hou; Zhao-Yong Sun; Hai-Long Zhou; Feng Feng; Wei-Hai Xu
Journal:  Neurology       Date:  2016-04-27       Impact factor: 9.910

Review 4.  MR angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease.

Authors:  A J Degnan; G Gallagher; Z Teng; J Lu; Q Liu; J H Gillard
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-22       Impact factor: 3.825

5.  Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease.

Authors:  Takao Hoshino; Leila Sissani; Julien Labreuche; Gregory Ducrocq; Philippa C Lavallée; Elena Meseguer; Céline Guidoux; Lucie Cabrejo; Cristina Hobeanu; Fernando Gongora-Rivera; Pierre-Jean Touboul; Philippe Gabriel Steg; Pierre Amarenco
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

Review 6.  Intracranial stenting in atherosclerotic disease-recent results and challenges to face.

Authors:  Wiebke Kurre; René Chapot; Richard du Mesnil de Rochemont; Joachim Berkefeld
Journal:  Neuroradiology       Date:  2010-03-30       Impact factor: 2.804

7.  Collateral perfusion using arterial spin labeling in symptomatic versus asymptomatic middle cerebral artery stenosis.

Authors:  Xin Lou; Xiaoxiao Ma; David S Liebeskind; Ning Ma; Chenglin Tian; Jinhao Lyu; Xiaojing Long; Lin Ma; Danny Jj Wang
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-08       Impact factor: 6.200

8.  Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results.

Authors:  W-J Jiang; X-T Xu; M Jin; B Du; K-H Dong; J-P Dai
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

9.  Chronic hemodynamic compromise and cerebral ischemic events in asymptomatic or remote symptomatic large-artery intracranial occlusive disease.

Authors:  H Yamauchi; T Higashi; S Kagawa; Y Kishibe; M Takahashi
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-07       Impact factor: 3.825

10.  Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue): procedural safety, efficacy, and midterm patency.

Authors:  Zsolt Vajda; Elina Miloslavski; Thomas Güthe; Elisabeth Schmid; Christoph Schul; Guido Albes; Hans Henkes
Journal:  Neuroradiology       Date:  2009-11-17       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.